STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended July 2, 2021. Second Quarter 2021 Overview Record Quarterly Net Sales of $62.4 Million Up 77% from the Prior Year Quarter Record Quarterly ICL Sales of $59.2 Million Up 93% from the Prior Year Quarter Record Quarterly ICL Units, Up 79% from the Pr